The cytotoxicity of trifluoromethyl boron derivatives and mode of action in human Tmolt3 T leukemic cells

Trifluoromethylboron derivatives proved to be cytotoxic in a number of murine and human leukemic and lymphoma screens. Solid tumor growth, e.g. glioma HS 683, breast Mck-7 and colon adenocarcinoma SW480, was reduced significantly by the compounds. Human Tmolt3 T-cell leukemia DNA synthesis was inhibited preferentially by the derivatives, with marginal effects on RNA and protein syntheses, after 60 min at 100 µM. The agents appeared to act by multiple mechanisms in that they inhibited the activities of DNA polymerase α, dihydrofolate reductase and nucleosides, significantly within 60 min at 100 µM. Deoxyribonucleotide pools were reduced after 60 min incubation with the compounds. Tmolt3 DNA fragmentation and reduced ct-DNA viscosity were evident after 24 h of incubation at 100 µM. ct-DNA thermal denaturation studies indicated that the agents caused some type of interaction with the bases of DNA. Copyright © 2000 John Wiley & Sons, Ltd.

[1]  Y. Chebude,et al.  ELECTROCHEMICAL AND OZONE OXIDATION OF (CF3)3B.NH3 : FORMATION AND CHARACTERIZATION OF PRODUCTS WITH NONDEGRADATED (CF3)3B GROUPS , 1999 .

[2]  C. C. Lee,et al.  Cytotoxicity of ferratricarbadecaboranyl complexes in murine and human tissue cultured cell lines. , 1998, Anticancer Research.

[3]  I. Hall,et al.  The synthesis and antitumor activity of metal complexes of amine-carboxyborane adducts , 1998 .

[4]  I. Hall,et al.  The Synthesis and Antitumor Activity of the Sodium Salt and Copper (II) Complex of N-[(Trimethylamineboryl)-Carbonyl]-L-Phenylalanine Methyl Ester , 1998, Metal-Based Drugs.

[5]  G. Pawelke On the reaction of dimethylamino-bis(trifluoromethyl) borane with sulphenes , 1997 .

[6]  I. Hall,et al.  Cytotoxic Action of Carboxyborane Heterocyclic Amine Adducts , 1997, Metal-based drugs.

[7]  G. Pawelke Trifluoromethylborane adducts of glycine , 1995 .

[8]  D. Brauer,et al.  AMINE ADDUCTS OF BIS(TRIFLUOROMETHYL)BORANE, (CF3)2BH, CRYSTAL AND MOLECULAR STRUCTURE OF (CF3)2BH.NME2CH2PH , 1995 .

[9]  D. J. Perkins,et al.  Synthesis and in vitro evaluation of boronated uridine and glucose derivatives for boron neutron capture therapy. , 1992, Journal of medicinal chemistry.

[10]  I. Hall,et al.  The anti‐neoplastic activity of ethylamine‐carboxyborane and triphenylphosphine‐carboxyborane in L‐1210 lymphoid leukemia cells , 1992 .

[11]  H. Hojo,et al.  Synthesis of carboranes containing nucleoside bases. Unexpectedly high cytostatic and cytocidal toxicity towards cancer cells , 1992 .

[12]  C. K. Sood,et al.  Synthesis and antineoplastic activity of some cyano-, carboxy-, carbomethoxy-, and carbamoylborane adducts of heterocyclic amines. , 1991, Journal of pharmaceutical sciences.

[13]  B. Laster,et al.  Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture. , 1991, Cancer research.

[14]  K. Morse,et al.  DNA interaction with metal complexes and salts of substituted boranes and hydroborates in murine and human tumor cell lines. , 1991, Anti-cancer drugs.

[15]  I. Hall,et al.  The antineoplastic activity of trimethylamine carboxyboranes and related esters and amides in murine and human tumor cell lines. , 1990, Anti-cancer drugs.

[16]  I. Hall,et al.  Synthesis, antineoplastic activity and biodistribution of boron analogues of amino acids and related compounds. , 1989, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[17]  K. Lee,et al.  Antimalarial agents. III. Mechanism of action of artesunate against Plasmodium berghei infection. , 1987, Chemical & pharmaceutical bulletin.

[18]  A. McPhail,et al.  Antineoplastic Activity of a Series of Boron Analogues of α-Amino Acids , 1985 .

[19]  A. McPhail,et al.  Hypolipidemic activity of tetrakis-mu-(trimethylamine-boranecarboxylato)-bis(trimethylamin e- carboxyborane)-dicopper(II) in rodents and its effect on lipid metabolism. , 1984, Journal of pharmaceutical sciences.

[20]  M. Ichihashi,et al.  Specific killing effect of 10B1-para-boronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vitro radiobiological evaluation. , 1982, The Journal of investigative dermatology.

[21]  W. E. Carey,et al.  Neutron capture using boronated monoclonal antibody directed against tumor-associated antigens. , 1982, Cancer detection and prevention.

[22]  T. Beerman,et al.  Induction of deoxyribonucleic acid damage in HeLa S3 cells by cytotoxic and antitumor sesquiterpene lactones. , 1981, Biochemical pharmacology.

[23]  C. Rawlings,et al.  Quantitative aspects of the formation and loss of DNA interstrand crosslinks in Chinese hamster cells following treatment with cis-diamminedichloroplatinum(II) (cisplatin). II. Comparison of results from alkaline elution, DNA renaturation and DNA sedimentation studies. , 1981, Biochimica et biophysica acta.

[24]  D. Hunting,et al.  Determination of deoxyribonucleoside triphosphates using DNA polymerase: a critical evaluation. , 1981, Canadian journal of biochemistry.

[25]  R. Christopherson,et al.  An overall radioassay for the first three reactions of de novo pyrimidine biosynthesis. , 1981, Analytical biochemistry.

[26]  C. Benz,et al.  The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. , 1981, The Journal of biological chemistry.

[27]  C. Chang,et al.  Biosynthesis of the boron-containing antibiotic aplasmomycin. Nuclear magnetic resonance analysis of aplasmomycin and desboroaplasmomycin. , 1980, The Journal of antibiotics.

[28]  I. Hall,et al.  Boron betaine analogs: antitumor activity and effects on Ehrlich ascites tumor cell metabolism. , 1979, Journal of pharmaceutical sciences.

[29]  N. Tanaka,et al.  Mechanism of action of macromomycin: DNA strand scission, inhibition of DNA synthesis and mitosis. , 1978, The Journal of antibiotics.

[30]  J. W. Phillips,et al.  New compounds: organoboron derivatives of tetracyclines I: synthesis of carboxamido derivative of tetracycline with perhydro-2-phenyl-1,3,6,2-dioxazaborocine. , 1977, Journal of pharmaceutical sciences.

[31]  D. Eichler,et al.  Effect of calcium on the recovery and distribution of DNA polymerase alpha from cultured human cells. , 1977, The Journal of biological chemistry.

[32]  A. Leibovitz,et al.  Classification of human colorectal adenocarcinoma cell lines. , 1976, Cancer research.

[33]  S. Osaki,et al.  Synthetic inhibitors of Escherichia coli, calf thymus, and Ehrlich ascites tumor thymidylate synthetase. , 1976, Journal of medicinal chemistry.

[34]  G. Russev,et al.  Some pyrazoles as inhibitors of purine biosynthesis de novo. , 1976, Biochemical pharmacology.

[35]  S. Horwitz,et al.  Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis. , 1976, Molecular pharmacology.

[36]  M. W. Williams,et al.  Toxic Effects of a New Boron Containing Heterocycle: 4,4,8,8-Tetraethyl-3,3a, 4,8-Tetrahydro 3a,4a,4-Diazabora-S-Indacene , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[37]  K. Anderson,et al.  Solubilized DNA-dependent nuclear RNA polymerases from the mammary glands of late-pregnant rats. , 1975, Biochimica et biophysica acta.

[38]  C. Piantadosi,et al.  Cycloalkanones. 4. Antifertility activity. , 1974, Journal of medicinal chemistry.

[39]  M. Sasada,et al.  Effect of neocarzinostatin on DNA synthesis in L1210 cells. , 1974, Cancer research.

[40]  D. Shaw,et al.  A common theme among ethical issues in oncology: the need to individualize advanced cancer care. , 1973 .

[41]  M. Hakala,et al.  5-(1-Adamantyl) pyrimidines as inhibitors of folate metabolism. , 1972, Cancer research.

[42]  L. R. Finch,et al.  Quantitative extraction and estimation of intracellular nucleoside triphosphates of Escherichia coli. , 1972, Analytical Biochemistry.

[43]  A. Dobrjansky,et al.  A rapid method for the isolation of nuclei from Ehrlich ascites tumor cells. , 1970, Cancer research.

[44]  Shealy Yf,et al.  Some organoboron compounds containing a bis(2-chloroethyl)amino group joined to boron. , 1969 .

[45]  A. Soloway,et al.  The alkylation and acylation of B-10H9NH3 negative. , 1969, Journal of Medicinal Chemistry.

[46]  M. A. Davis,et al.  Carboranes. 3. Boron-containing acridines. , 1967, Journal of medicinal chemistry.

[47]  M. A. Davis,et al.  Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. , 1967, Journal of medicinal chemistry.

[48]  Moore Ec,et al.  Regulation of Mammalian Deoxyribonucleotide Biosynthesis by Nucleotides as Activators and Inhibitors , 1966 .

[49]  A. Soloway,et al.  Boron hydride anions. I. Nitrogen mustards. , 1966, Journal of Medicinal Chemistry.

[50]  Soloway Ah,et al.  Carboranes. I. Nitrogen mustards. , 1966 .

[51]  T. Brzozowski,et al.  Purification and properties of a bacterial carbamyl phosphate synthetase. , 1966, The Journal of biological chemistry.

[52]  S. Ochoa,et al.  Enzymatic phosphorylation of deoxycytidylic acid. , 1958, The Journal of biological chemistry.

[53]  P. Cohen,et al.  Colorimetric determination of carbamylamino acids and related compounds. , 1954, The Journal of biological chemistry.

[54]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[55]  R. Archibald DETERMINATION OF CITRULLINE AND ALLANTOIN AND DEMONSTRATION OF CITRULLINE IN BLOOD PLASMA , 1944 .